VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

live attenuated Brucella abortus strain 2308 delta NodV delta NodW vaccine
Vaccine Information
  • Vaccine Name: live attenuated Brucella abortus strain 2308 delta NodV delta NodW vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009375
  • Type: Live attenuated vaccine
  • Status: Research
  • Host Species for Licensed Use: Cattle
  • Host Species as Laboratory Animal Model: Mus musculus; RAW 264.7 murine macrophages; BALB/c mice
  • Antigen: NodV and NodW (two-component regulatory system genes deleted)
  • Preparation: Live attenuated double mutant strain 2308 with deletions in NodV and NodW genes; no adjuvant reported. (Li et al, 2017)
  • Description: The vaccine is a double deletion mutant of virulent Brucella abortus strain 2308, deleting the NodV and NodW genes encoding a two-component regulatory system on chromosome II, constructed to reduce virulence and allow serological differentiation from infected animals. Efficacy: The mutant showed significantly reduced survival in macrophages and mice, no splenomegaly in inoculated mice, and conferred high protective immunity against challenge with wild-type strain 2308 in BALB/c mice. Immune response: Induced anti-Brucella-specific IgG antibody response; stimulated secretion of gamma interferon (IFN-γ) and interleukin-4 (IL-4), indicating activation of both Th1 and Th2 immune responses. (Li et al, 2017)
Host Response

Mouse Response

  • Host Strain: BALB/c
  • Immune Response: Induced anti-Brucella-specific IgG antibody response; stimulated secretion of gamma interferon (IFN-γ) and interleukin-4 (IL-4), indicating activation of both Th1 and Th2 immune responses. (Li et al, 2017)
  • Challenge Protocol: Survival assays in murine macrophage cell line RAW 264.7; infection and protection studies in BALB/c mice including challenge with wild-type strain 2308; measurement of splenomegaly; serological assays for IgG; cytokine secretion assays for IFN-γ and IL-4. (Li et al, 2017)
  • Efficacy: The mutant showed significantly reduced survival in macrophages and mice, no splenomegaly in inoculated mice, and conferred high protective immunity against challenge with wild-type strain 2308 in BALB/c mice. (Li et al, 2017)
  • Description: Survival assays in murine macrophage cell line RAW 264.7; infection and protection studies in BALB/c mice including challenge with wild-type strain 2308; measurement of splenomegaly; serological assays for IgG; cytokine secretion assays for IFN-γ and IL-4. (Li et al, 2017)
References
Li et al, 2017: Li Z, Wang S, Zhang J, Yang G, Yuan B, Huang J, Han J, Xi L, Xiao Y, Chen C, Zhang H. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice. Microbial pathogenesis. 2017 May; 106; 30-39. [PubMed: 28131952].